Corrigendum to immunopeptidomics analysis of human atherosclerosis plaques identifies antigenic drivers of atherosclerosisAtherosclerosis, (409), October 2025, 120509 | Synapse
March 3, 2026
Corrigendum to immunopeptidomics analysis of human atherosclerosis plaques identifies antigenic drivers of atherosclerosisAtherosclerosis, (409), October 2025, 120509
Key Points
The analysis reveals specific antigens that may be significant in understanding atherosclerosis.
Key findings include the identification of biomarkers relevant to plaque composition and immune response.
This analysis utilizes immunopeptidomics to uncover antigenic drivers underlying atherosclerotic processes.
Insights from this work may enhance strategies for diagnosing and treating atherosclerosis.